宝莫股份(002476) - 2015 Q4 - 年度财报

Financial Performance - The company's operating revenue for 2015 was ¥741,646,821.97, an increase of 11.09% compared to ¥667,606,686.28 in 2014[17]. - The net profit attributable to shareholders decreased by 49.62% to ¥24,138,430.85 from ¥47,909,790.59 in the previous year[17]. - The net profit after deducting non-recurring gains and losses was ¥9,121,485.03, down 71.78% from ¥32,320,733.82 in 2014[17]. - The net cash flow from operating activities improved significantly to ¥122,179,911.35, a 214.80% increase from -¥106,427,237.21 in 2014[17]. - The total assets at the end of 2015 were ¥1,547,861,204.30, reflecting a 13.33% increase from ¥1,365,849,300.17 at the end of 2014[17]. - The weighted average return on equity decreased to 2.37% from 4.75% in the previous year[17]. - The company reported a basic earnings per share of ¥0.0394, down 49.68% from ¥0.0783 in 2014[17]. - The company reported a significant asset impairment of 49,295,094.48 CNY, primarily due to the impairment of oil and gas assets[72]. - The company reported a net loss of approximately 10.9 million, indicating a decline in profitability[89]. Dividend Policy - The company plans to distribute a cash dividend of 0.3 RMB per 10 shares to all shareholders based on the total share capital as of December 31, 2015[5]. - In 2015, the company distributed cash dividends of RMB 18,360,000, representing 76.06% of the net profit attributable to shareholders[108]. - The company has maintained a consistent cash dividend policy over the past three years, with a cash dividend of RMB 0.30 per share[109]. Research and Development - The company reported a significant focus on R&D for new products and technologies, aiming to enhance its market position[12]. - R&D investment amounted to 21,936,274.23 CNY, accounting for 2.96% of operating revenue, with a year-on-year increase of 4.71%[66]. - The company has allocated 100 million RMB for R&D in 2016, focusing on innovative technologies in biochemistry[163]. - The company plans to increase R&D investment, targeting key technologies in oil and gas exploration and environmental water treatment[97]. Business Operations and Strategy - The company has not experienced any changes in its main business operations since its listing, indicating stability in its strategic direction[16]. - The company emphasizes the importance of risk factors that may affect future performance, urging investors to remain cautious[5]. - The company’s management has highlighted the importance of strategic planning for future growth and market expansion[12]. - The company is committed to strategic transformation and enhancing its long-term development capabilities[99]. - The company is focusing on the research and development of biopharmaceutical products and related technical services[88]. - The company aims to enhance its technical services in oilfield chemical sales and environmental engineering[89]. Market and Revenue Sources - The chemical business generated revenue of CNY 631.36 million, up 4.15% year-on-year, primarily due to breakthroughs in overseas market sales[46]. - The oilfield technical service revenue was CNY 59.92 million, down 2.43% compared to the previous year[46]. - The oil and gas exploration and development business generated revenue of CNY 50.37 million, resulting from the oil production of the acquired oilfield blocks by the subsidiary, Sharp Energy[46]. - The company’s foreign revenue surged by 1,009.86%, reaching ¥233,760,993.75, while domestic revenue decreased by 21.45% to ¥507,885,828.22[51]. Asset Management and Investments - The company’s investment activities resulted in a net cash outflow of ¥245,940,736.04, a decrease of 853.79% year-on-year, primarily due to acquisitions of oil and gas assets[48]. - The company acquired oil and gas assets in Canada, with a remaining recoverable reserve of approximately 3 million barrels in the Bashaw, Redwater, and Galahad oil fields[43]. - The company is actively participating in the bidding for oil and gas exploration blocks, winning a bid for the Buerjin block, which is expected to have geological reserves of 7-10.4 million tons of oil[43]. Corporate Governance - The company’s financial report is guaranteed to be true, accurate, and complete by its board of directors and management, ensuring accountability[4]. - The company has established a comprehensive talent management system to support its new business initiatives in oil and gas engineering and environmental services[102]. - The board of directors consists of 8 members, including 3 independent directors, ensuring compliance with governance standards[180]. - The audit committee confirmed that the audit report from Deloitte Touche Tohmatsu CPA Ltd. fairly reflects the financial status of the company as of December 31, 2015, and its operational results and cash flows for the year 2015[196]. Shareholding and Ownership - The company has not undergone any changes in its controlling shareholders, indicating stability in ownership[16]. - The largest shareholder, Shengli Oilfield Chang'an Holding Group Co., Ltd., holds 18.10% of the shares, totaling 110,780,706 shares, with a decrease of 159,519 shares during the reporting period[145]. - The company reported that the controlling shareholder, Shengli Oilfield Chang'an Holding Group Co., Ltd., has not changed during the reporting period[148]. Environmental and Social Responsibility - The company is focusing on environmental protection projects, leveraging new policies to expand its market presence in oilfield environmental services[41]. - The company is focusing on the oilfield environmental protection market, particularly in high-temperature and high-salinity oil wastewater treatment[94]. - The company aims to create a national-level enterprise technology center to support industry development through innovation[97].